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Introduction {#sec1}
============

Amyotrophic lateral sclerosis (ALS) is a fatal, adult-onset neurodegenerative disorder in which there is selective loss of motor neurons in the cerebral cortex, brainstem, and spinal cord ([@bib22]). Approximately 90% of ALS cases are sporadic with unknown etiology; the remaining 10% are inherited and known as familial ALS (fALS), of which over 20% have mutations in the gene encoding Cu/Zn superoxide dismutase 1 (SOD1) ([@bib7]). To date, over 155 different mutations have been identified in SOD1 either in isolated cases of ALS or more commonly in patients from families showing autosomal dominant patterns of inheritance ([@bib2], [@bib38]). ALS-linked SOD1 mutations are thought to induce a toxic gain of function in the protein, which becomes prone to misfolding and subsequent aggregation ([@bib27], [@bib45]). However, expression of mutant SOD1 can affect a number of cellular processes, causing ER distress, mitochondrial dysfunction, excitotoxicity, defects in axonal transport, and inhibition of the proteasome ([@bib21]). Despite being the first gene identified with mutations that cause fALS ([@bib44]) and providing the basis of the first ALS animal model ([@bib17]), there is still no consensus about how mutant SOD1 specifically alters motor neuron physiology.

Although most studies have focused on the cellular mechanisms and genes that induce motor neuron death in ALS, less is known about the neurons that do survive, including their ability to resist stress-induced cell death and to compensate for dying motor neurons. Not all motor neurons are equally susceptible to cell death during ALS disease progression. ALS mostly targets motor neurons required for voluntary movement, whereas motor neurons of the autonomic system are less sensitive ([@bib40]). There is also a gradient of vulnerability among spinal motor neurons, whereby faster motor units become affected before slower muscle types ([@bib41]). Motor neurons that are less ALS susceptible can compensate for the cells that initially die by establishing new connections with the motor endplate, although many of these will eventually succumb to the disease ([@bib48]). This selective neuronal vulnerability is present in both sporadic ALS and familial ALS and is also recapitulated in rodent models, such as the SOD1^G93A^ mouse ([@bib17], [@bib35]).

Most of our current knowledge about surviving spinal motor neurons in ALS mouse models has largely been generated by gene expression profiling of tissue and cells ([@bib3], [@bib6], [@bib11], [@bib12], [@bib30], [@bib47]). However, these studies provide just a single snapshot of the motor neuron\'s biology and only allow for inferences to be made about how changes in gene expression alter motor neuron physiology, allow them to resist degeneration, or compensate for dying neurons by forming new motor endplate attachments. In the current study, we sought to functionally characterize ALS-resistant motor neurons by culturing them *in vitro*, where we would be able to directly assess dynamic cellular properties such as outgrowth, branching, and regulation of the cytoskeleton.

Results {#sec2}
=======

Axon Outgrowth and Branching Are Increased in Adult Motor Neurons from Symptomatic SOD1-ALS Mice {#sec2.1}
------------------------------------------------------------------------------------------------

To functionally characterize ALS-resistant motor neurons, we isolated them from adult mice expressing human SOD1^G93A^ at low copy number (referred to as G93A-DL) ([@bib1]). This model expresses between six and eight copies of the human SOD1^G93A^ transgene, resulting in the onset of ALS symptoms around 9 months of age. We corroborated these findings with the more extensively studied SOD1^G93A^ high copy number mouse model (referred to as G93A), which expresses SOD1^G93A^ at around 3-fold that of the G93A-DL model. These mice develop symptoms more rapidly, with hindlimb paralysis seen as early as 5 months of age ([@bib17]). Using a well-characterized protocol for the high yield extraction of spinal motor neurons from adult mice ([@bib4]), we established cultures of adult motor neurons ([Figure S1](#mmc1){ref-type="supplementary-material"}) from mutant SOD1 and non-transgenic mice (referred to as NTg). We then performed a large-scale quantitative analysis of these cells\' ability to extend new processes. Since the isolation protocol severs all established neuronal projections, this assay is a direct measure of *in vitro* neurite regeneration.

Motor neurons from G93A-DL mice displayed significantly increased outgrowth in comparison with age- and sex-matched NTg controls, both in axon length (∼55% longer) and in overall neurite branching complexity (approximately three times as many intersections 60 μm from the soma center) ([Figures 1](#fig1){ref-type="fig"}A--1D and [S2](#mmc1){ref-type="supplementary-material"}). Motor neurons isolated from late-stage G93A mice also demonstrated increased neurite branching and axonal outgrowth relative to NTg mice ([Figures 1](#fig1){ref-type="fig"}C and 1D). In contrast, motor neurons from adult mice overexpressing wild-type SOD1 (WT SOD1) exhibited a slight decrease in outgrowth and branching ([Figures 1](#fig1){ref-type="fig"}C and 1D). This was an important control since the SOD1^G93A^ mutant maintains its enzymatic ability to remove superoxide radicals ([@bib36]). The reduction in axon extension and branching in motor neurons from WT SOD1 mice is consistent with previous findings where ROS depletion results in negative effects on neurite outgrowth ([@bib33]). Thus, the enhanced regeneration seen in late-stage motor neurons is specific to the SOD1^G93A^ ALS mice and occurs with both high and low expression levels of the mutant gene.Figure 1Adult Motor Neurons Cultured from Symptomatic SOD1^G93A^ ALS Mouse Models Have Enhanced Axonal Outgrowth and Neurite Branching(A) Confocal images of representative motor neurons harvested from non-transgenic (NTg), low-copy-number SOD1^G93A^ (G93A-DL), SOD1^G93A^ (G93A), and wild-type SOD1 (WT) transgenic mice. Motor neurons from both strains of SOD1^G93A^ mice were harvested at their respective symptomatic stages (approximately 9 months for G93A-DL and approximately 6 months for G93A), and motor neurons from WT mice were harvested at 6 months of age. Scale bar represents 30 μm.(B) Representative images of motor neurons harvested from NTg and ALS symptomatic G93A-DL mice. These are the traced, segmented neurites that were used for Sholl analysis. The original images can be found in [Figure S3](#mmc1){ref-type="supplementary-material"}. The pseudocolor image of G93A-DL motor neuron demonstrates the number of intersections measured at progressive distances from the soma. Scale bar represents 50 μm. The line graph represents the average number of intersections measured at a given distance from the soma for all NTg or G93A-DL neurons.(C) Box-and-whisker plots of the axonal outgrowth (measured as the length of the longest neurite branch) of motor neurons cultured from G93A-DL, G93A, and WT mice relative to their age-matched non-transgenic (NTg) controls.(D) Branching of motor neurons was quantified by measuring the average number of intersections found 60 μm from the center of the soma (noted as dotted line in \[B\]). Bar graphs depict motor neuron arborization seen in G93A-DL, G93A, and WT motor neurons compared with their respective NTg controls. For (C) and (D): G93A-DL dataset: n = 56 cells from three NTg mice and n = 62 cells from three G93A-DL mice; G93A dataset: n = 88 cells from four NTg mice and n = 120 cells from five G93A mice; WT dataset: n = 82 cells from two NTg mice and n = 89 cells from three WT mice.(E) Representative images of G93A-DL and G93A growth cones of motor neurons harvested from symptomatic mice with representative NTg growth cone. Scale bar represents 5 μm.(F--H) Plots depicting growth cone area, average filopodia length filopodia per growth cone, and number of filopodia per growth cone demonstrated in G93A and G93A-DL motor neurons from symptomatic mice relative to their NTg controls. For (F--H) n = 25 for NTg and n = 25 for G93A-DL, harvested from two mice for each for G93A-DL dataset; n = 38 cells for NTg and n = 28 cells for G93A, harvested from two mice each for G93A dataset; and n = 30 from two mice for NTg and n = 45 from three mice for WT dataset.(I) Representative images of NTg, G93A-DL, and G93A axonal filopodia. Scale bar represents 10 μm.(J) Bar graph of axonal filopodia density of G93A-DL, G93A, and WT-SOD1 motor neurons compared with age- and sex-matched control cells. n = 46 cells from four mice for NTg and n = 49 cells from four mice for G93A-DL, and n = 30 cells from two mice for both NTg and G93A; n = 30 from two mice for NTg and n = 45 from three mice for WT dataset.Box-and-whisker plots denote the 95th (top whisker), 75th (top edge of box), 25th (bottom edge of box), and 5th (bottom whisker) percentiles and the median (bold line in box). Data in bar graphs are represented as mean ±95% confidence intervals. p Values were obtained from a two-tailed Student\'s t test.

Actin-Based Structures Are Increased in Adult Motor Neurons from Symptomatic SOD1-ALS Mice {#sec2.2}
------------------------------------------------------------------------------------------

Growth cones are the motile organelles found at the tip of axonal and dendritic projections that play a pivotal role in outgrowth and pathfinding, including during *in vivo* adult motor neuron regeneration ([@bib25]). The peripheral region of the growth cone contains actin-based lamellipodia and filopodia, two types of membrane protrusions that function in growth cone movement and environment sensing ([@bib53]). We observed a marked increase in the size of growth cones and filopodia in spinal motor neurons isolated from symptomatic G93A-DL and G93A mice. G93A-DL growth cones were on average greater than twice the size of those from NTg controls; G93A growth cones exhibited a similar increase in size ([Figures 1](#fig1){ref-type="fig"}E and 1F). Growth cone filopodia from both ALS mouse lines were also significantly longer than those from NTg controls, with G93A-DL cells exhibiting the largest size difference ([Figure 1](#fig1){ref-type="fig"}G). G93A-DL growth cones also contained more filopodia ([Figure 1](#fig1){ref-type="fig"}H). Growth cones from WT-SOD1 motor neurons were not significantly larger than those from NTg controls, nor did they have an increased number of filopodia ([Figure 1](#fig1){ref-type="fig"}F). However, the filopodia that were present were significantly longer ([Figure 1](#fig1){ref-type="fig"}G).

Axonal filopodia are actin-based structures extending off of the main axon terminal that serve as precursors for collateral branches, which are involved in building complex neural circuits ([@bib14]). In ALS, the formation of new collateral branches occurs in the resistant motor units as they attempt to expand their synaptic connections to compensate for early denervation events ([@bib9], [@bib48]). In motor neurons isolated from both G93A-DL and G93A mice, we observed a marked increase in axonal filopodia density relative to NTg controls ([Figures 1](#fig1){ref-type="fig"}I and 1J). There was no difference in axonal filopodia of motor neurons from WT SOD1 mice compared with the NTg controls ([Figure 1](#fig1){ref-type="fig"}J). Thus, the surviving motor neurons isolated from symptomatic ALS mice exhibit an upregulation of multiple actin-based structures associated with outgrowth and regeneration.

Enhanced Regeneration of Mutant SOD1 Motor Neurons Occurs Only in Adult Cells and Is Independent of ALS Onset {#sec2.3}
-------------------------------------------------------------------------------------------------------------

Our results were surprising since previous studies have shown that the expression of G93A is either inhibitory or has no effect on outgrowth and regeneration in motor neurons. However, these studies were conducted using either embryonic cells ([@bib34]) or iPSC-derived motor neurons ([@bib23], [@bib28]), which more closely resemble the embryonic state ([@bib19]) and may respond differently to the mutant SOD1expression. When we cultured motor neurons from G93A-DL and NTg pups at E14, there was no significant difference observed in outgrowth or branching after 3 days *in vitro* (DIV) ([Figures 2](#fig2){ref-type="fig"}A and 2B). We then cultured motor neurons from adult G93A-DL mice at different time points prior to the onset of ALS symptoms (1, 2, and 6 months of age). Increased axonal outgrowth and neurite branching relative to NTg controls were observed at the 2- and 6-month time points, with a more significant difference at 6 months ([Figures 2](#fig2){ref-type="fig"}C and 2D). These data reveal a trend whereby regeneration is enhanced relative to NTg controls as the mice age and become closer to developing ALS. However, if the actual size of the processes is plotted instead of their relative size (to NTg controls), G93A-DL motor neurons maintain the same level of outgrowth (axon is ∼120 μm) throughout their lifespan, whereas NTg motor neurons actually become progressively smaller. The same trend exists for branching ([Figure 2](#fig2){ref-type="fig"}D). This could be interpreted as G93A-DL motor neurons having a preserved, rather than an enhanced, ability to regenerate.Figure 2Enhanced Outgrowth and Branching of Adult Motor Neurons from Mutant SOD1 Mice Is Specific to Adult Cells and Independent of ALS Onset(A) Representative images and Sholl graph of E14 motor neurons harvested from NTg and G93A-DL mice and imaged after 2 DIV. Scale bar represents 100 μm.(B) Box-and-whisker plot and bar graph showing axonal outgrowth (neuron radius) and neurite branching (number of intersections found 60 μm from the center of the soma, noted as dotted line in \[A\]) measurements for embryonic NTg and G93A-DL motor neurons.(C) Representative images of adult motor neurons harvested at 2, 6, and 9 months from NTg and G93A-DL mice. Scale bar represents 50 μm.(D) Line graphs depicting axonal outgrowth and neurite branching as a function of age. For the dataset taken at 1 month, n = 49 for NTg and n = 47 for G93A-DL, taken from three mice each; for 2 months n = 95 for NTg and n = 80 for G93A-DL, harvested from three mice each. Data representing 6 months was taken from three mice each for NTg and G93A-DL, with n = 88 and n = 80, respectively. Data representing symptomatic stage (indicated with red rectangle) was taken from three NTg mice and three G93A-DL mice, with n = 56 and n = 62, respectively. Asterisk indicates p value of less than 0.001.(E) Representative images and Sholl graph of motor neurons harvested from NTg and G85R mice at 5 months of age. Scale bar represents 50 μm.(F) Box-and-whisker plot and bar graph showing axonal outgrowth (neuron radius) and neurite branching (number of intersections found 60 μm from the center of the soma, noted as dotted line in \[E\]) measurements for G85R and NTg motor neurons. n = 23 from two mice for NTg and n = 51 from three mice for G85R.Box-and-whisker plots denote the 95th (top whisker), 75th (top edge of box), 25th (bottom edge of box), and 5th (bottom whisker) percentiles and the median (bold line in box). Data in bar graphs are represented as mean ±95% confidence intervals. p Values were obtained from a two-tailed Student\'s t test. The images of motor neurons in A, C, and E are the traced, segmented neurites that were used for Sholl analysis. The original images can be found in [Figure S3](#mmc1){ref-type="supplementary-material"}.

To verify that enhanced outgrowth of adult motor neurons from mutant SOD1 mouse models occurs independently of developing ALS, we isolated cells from transgenic mice overexpressing YFP-SOD1^G85R^. YFP-SOD1^G85R^ homozygous mice develop ALS, whereas the heterozygous mice (referred to as G85R-het) do not develop symptoms ([@bib8], [@bib54]). Thus, the heterozygous model is a useful tool for studying the effects of mutant SOD1 overexpression independently of the effects of ALS progression. Motor neurons were isolated from G85R-het mice at 5 months of age, which is when the G93A mice typically start to show symptoms of ALS and also an age where pre-symptomatic G93A-DL mice still have substantial increases in outgrowth and branching relative to controls ([Figures 1](#fig1){ref-type="fig"}C, 1D, and [2](#fig2){ref-type="fig"}D). G85R-het motor neurons exhibited an increase in axon length and neurite branching comparable with that seen in end-stage G93A mice ([Figures 2](#fig2){ref-type="fig"}E and 2F). Thus, expression of mutant SOD1 can enhance regeneration independently of ALS symptoms even in a model in which there is no selection for surviving cells or stress from motor neuron death that signals the remaining neurons to reinnervate lost connections ([@bib20]). This strongly suggests that it is the expression of mutant SOD1, not external factors caused by ALS, which increases outgrowth and regeneration of adult motor neurons.

Expression of SOD1^G93A^ Enhances Outgrowth and Branching of Wild-Type Adult Motor Neurons {#sec2.4}
------------------------------------------------------------------------------------------

All of the experiments described earlier are performed with animal models where the cells express a mutant transgene for months *in vivo*. In fact, the enhanced outgrowth and branching phenotypes becomes apparent only after the mouse is 2 months old ([Figure 2](#fig2){ref-type="fig"}D). Therefore, it could be argued that enhanced regeneration is the result of an accumulated effect caused by long-term expression of the mutant gene, thus explaining the differences seen between adult ([Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}) and embryonic motor neurons ([Figures 2](#fig2){ref-type="fig"}A and 2B). To determine if acute expression of SOD1^G93A^ was sufficient to increase outgrowth and branching in adult motor neurons, we cultured wild-type cells from 9- to 12-month-old NTg mice and transduced them with adeno-associated virus (AAV) to express wild-type SOD1 (WT-YFP), SOD1^G93A^ (G93A-YFP), or a GFP control. Interestingly, acute expression of G93A-YFP was sufficient to increase axonal outgrowth relative to NTg motor neurons ([Figures 3](#fig3){ref-type="fig"}A and 3B). Although branching was not significantly increased, there was a significant positive correlation between G93A-YFP expression levels and both outgrowth parameters measured ([Figure 3](#fig3){ref-type="fig"}C). The difference between cells expressing G93A-YFP and WT-YFP was even more significant for outgrowth and branching ([Figure 3](#fig3){ref-type="fig"}B). WT-YFP-positive cells did not have statistically significant differences in outgrowth or branching relative to GFP controls, but expression of WT-YFP was negatively correlated with outgrowth, mimicking the trend observed in the SOD1 overexpressing transgenic mouse models ([Figure 1](#fig1){ref-type="fig"}). Thus, acute expression of mutant SOD1 was sufficient to increase regeneration of wild-type adult motor neurons.Figure 3Acute Expression of SOD1^G93A^ Increases Outgrowth and Branching in Non-transgenic Adult Motor Neurons(A) Representative images of NTg motor neurons from 9- to 12-month-old mice transduced with AAV to overexpress GFP, wild-type SOD1-YFP (WT-YFP), or SOD1^G93A^-YFP (G93A-YFP). Scale bar represents 50 μm.(B) Box-and-whisker plot depicting axonal outgrowth (neuron radius) and bar graph showing branching (number of intersections found 100 μm from the center of the soma) measurements of transduced NTg motor neurons. n = 38 cells from six mice, n = 37 cells from six mice, and n = 48 cells from six mice for AAV-GFP, AAV-WT-YFP, and AAV-G93A-YFP, respectively.(C) Scatterplot depicting the relationship between the mean cellular fluorescence intensity of G93A-YFP axon outgrowth and neurite branching. Pearson\'s correlation coefficient (Pearson) R values are depicted under the respective bars in (B). R values were reported only if the correlation was statistically significant (p \< 0.05); otherwise, they are listed as not significant (n.s.). n = 46, n = 45, and n = 57 for NTg motor neurons infected with AAV-GFP, AAV-WT-YFP, and AAV-G93A-YFP, respectively; cells harvested from nine mice (three trials, three mice/trial).Box-and-whisker plots denote the 95th (top whisker), 75th (top edge of box), 25th (bottom edge of box), and 5th (bottom whisker) percentiles and the median (bold line in box). Data in bar graphs are represented as mean ±95% confidence intervals. p Values were obtained by ANOVA followed by Tukey\'s *post hoc* test.

SOD1^G93A^ Increases Axonal Filopodia and Localizes to Actin-Based Structures {#sec2.5}
-----------------------------------------------------------------------------

Since actin-based structures were upregulated in motor neurons from G93A mouse models ([Figures 1](#fig1){ref-type="fig"}E--1J), we wanted to determine if expression of SOD1^G93A^ was sufficient to increase such structures in wild-type motor neurons. Cells from NTg mice were infected with AAV expressing GFP, WT-SOD1-YFP (WT-YFP), and G93A-YFP, after which axonal filopodia were measured. Quantification of growth cone parameters was not possible because of the length of time the cells were cultured to achieve robust transgene expression (10 DIV compared with 3 DIV for our analysis of end-stage G93A/G93A-DL motor neurons). Growth cones are most prevalent at 3 DIV. By 10 DIV few cells still had growth cones, but filopodia were still ubiquitously present on neurite projections, so we quantified axonal filopodia density. Both WT-YFP- and G93A-YFP-expressing cells had significantly higher axonal filopodia densities compared with GFP-expressing cells, with G93A-YFP-expressing cells having the largest increase in filopodia ([Figure 4](#fig4){ref-type="fig"}A). G93A-YFP expression resulted in a 33% increase in filopodia density over SOD1-YFP and a 100% increase over GFP ([Figure 4](#fig4){ref-type="fig"}A). Furthermore, we observed that G93A-YFP was localized to actin-based structures such as growth cones (the few that were present) and filopodia more than SOD1-YFP ([Figure 4](#fig4){ref-type="fig"}B).Figure 4SOD1^G93A^ Localizes to and Increases Filopodia(A) Representative images and quantification of axonal filopodia density (measured on the longest projection) from AAV-GFP-, AAV-WT-YFP-, or AAV-G93A-YFP-transduced NTg motor neurons. n = 38 cells from six mice, n = 37 cells from six mice, and n = 48 cells from six mice for AAV-GFP, AAV-SOD1-YFP, or AAV-G93A-YFP, respectively. Scale bar represents 50 μm.(B) Confocal images of neurites from NTg adult motor neurons transduced with AAV-WT-YFP and AAV-G93A-YFP. Arrows indicate localization of G93A-YFP to filopodia. Scale bar represents 5 μm.(C) Representative images of neurite-like projections in Cath-a-differentiated (CAD) cells that have been transfected with YFP, wild-type SOD1-YFP (WT-YFP), or SOD1^G93A^-YFP (G93A-YFP). Scale bar represents 5 μm.(D) Bar graph measuring filopodia density in CAD cells transfected with YFP, WT-YFP, or G93A-YFP. n = 71 cells for YFP, n = 48 cells for SOD1-YFP, and n = 72 for G93A-YFP, three separate transfections per condition.(E) Enlarged view of YFP fluorescence from dashed boxes from (C) showing the increased localization of G93A-YFP into filopodia compared with WT-YFP. Scale bar represents 1 μm.(F) Box-and-whisker plot quantifying YFP fluorescence intensity in filopodia in CAD cells. n = 1,359 filopodia from 38 cells for YFP, n = 1,367 filopodia from 40 cells for WT-YFP, and n = 1,524 from 39 cells for G93A-YFP, three separate transfections per condition.Box-and-whisker plots denote the 95th (top whisker), 75th (top edge of box), 25th (bottom edge of box), and 5th (bottom whisker) percentiles and the median (bold line in box). Data in bar graphs are represented as mean ±95% confidence intervals. p Values were obtained by ANOVA followed by Tukey\'s *post hoc* test.

To determine if the localization to, and enhancement of, filopodia by SOD1^G93A^ is a general phenomenon, we overexpressed G93A-YFP, WT-SOD1-YFP (WT-YFP), or YFP in Cath-a-differentiated (CAD) cells. CAD cells are a CNS-derived cell line that extend neurite-like projections that are highly similar to actual neurites upon serum withdrawal ([@bib42]) that contain numerous filopodia ([@bib26]). Transfected CAD cells were differentiated for 18 hr, labeled with phalloidin, and then imaged using deconvolution-based super-resolution confocal microscopy ([@bib57]). Filopodia were segmented and analyzed with the ImageJ plugin Filopodyan ([@bib52]), which allowed us to measure the hundreds of individual filopodia per condition. We observed a significant increase in the localization of WT-YFP and G93A-YFP into filopodia over the YFP control, with G93A having the most robust filopodia localization ([Figures 4](#fig4){ref-type="fig"}C, 4E, and 4F). This is consistent with previous work showing that both WT and G93A SOD1 bind actin, but the interaction is increased with the G93A mutant ([@bib51]). Additionally, we observed an increase in filopodia density when G93A-YFP was expressed ([Figure 4](#fig4){ref-type="fig"}D) that was similar to experiments performed with adult motor neurons ([Figure 4](#fig4){ref-type="fig"}A). Thus, SOD1^G93A^ localizes to and increases filopodia in multiple cell types, indicating it is a general mechanism of actin regulation.

Discussion {#sec3}
==========

This study demonstrates that SOD1^G93A^ expression can have pro-regenerative effects on adult motor neurons. Not only was enhanced neurite regeneration observed in motor neurons isolated from mutant SOD1 transgenic mice ([Figure 2](#fig2){ref-type="fig"}) but also the expression of SOD1^G93A^ alone was sufficient to increase outgrowth in non-transgenic primary motor neurons ([Figure 3](#fig3){ref-type="fig"}). Furthermore, SOD1^G93A^ localized to actin-based cellular structures and increased their size and number ([Figure 4](#fig4){ref-type="fig"}). Finally, an important take-home message from this study is the importance of working with the right cell type, as mutant SOD1 expression had no effect on embryonic motor neuron regeneration ([Figures 2](#fig2){ref-type="fig"}A and 2B) but had a substantial effect on adult motor neuron outgrowth and branching ([Figures 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"}, and [3](#fig3){ref-type="fig"}). Although it has been speculated that upregulation of regenerative/injury pathways is merely a compensatory response to mutant-SOD1-induced toxicity ([@bib30], [@bib41]), our work suggests a novel gain of function for mutant SOD1, where it can help preserve motor neuron plasticity.

There are two mechanisms through which this could occur. The first is a direct regulation of actin by mutant SOD1. Although the relationship between mutant SOD1 and the actin cytoskeleton is not well characterized, it has been shown that SOD1^G93A^ directly interacts with actin ([@bib51], [@bib59]). Interestingly, mutant SOD1 has a significantly higher affinity for actin than the wild-type protein ([@bib51]). That SOD1 is found in filopodia is also of interest. Since filopodia are extremely thin (∼200 nm) extensions of the cellular membrane that are tightly packed with rearward-flowing actin filaments ([@bib32]), localization there strongly indicates a specific interaction ([@bib5]). It also might suggest that SOD1 preferentially binds or bundles linear arrays of filaments since the most prevalent structures we found to be upregulated by expression of mutant SOD1 were axonal filopodia. Axonal filopodia are precursor membrane protrusions to collateral branches ([@bib14]). New collateral branches form during the early stages of ALS, when the resistant neurons try to establish new synaptic connections to compensate for the denervation caused by the loss of the most susceptible neurons ([@bib9], [@bib48]). Axonal filopodia must recruit microtubules to become collateral branches ([@bib29]). Interestingly, in addition to actin, mutant SOD1 can also interact with the microtubule cytoskeleton ([@bib24]). Thus, mutant SOD1 may have a dual role in the formation of new branches by increasing axonal filopodia ([Figures 4](#fig4){ref-type="fig"}A and 4D) and then helping microtubules to enter them. However, future studies will be required to determine if mutant SOD1 is directly involved in cytoskeletal regulation.

The second way that mutant SOD1 expression could enhance outgrowth and branching would be through upregulation of pro-regenerative signaling and cytoskeletal pathways. There are several published studies characterizing genetic changes in motor neurons from G93A mice at various stages of disease progression ([@bib10], [@bib11], [@bib12], [@bib16], [@bib37], [@bib39], [@bib46], [@bib58]). However, these studies have not reached consensus regarding the underlying genetics promoting ALS resistance, probably because of the variation in experimental design and tissue sampling. For example, using G93A mice, one study found a massive upregulation of genes involved in cell growth and/or maintenance in micro-dissected motor neurons from the lumbar spinal cord ([@bib39]), whereas another study found Wnt signaling to be significantly activated when homogenized whole spinal cord was used for RNA extraction ([@bib58]). It has also been shown that upregulation of axonal guidance genes and actin cytoskeletal genes (including α-actin and β-actin) occurs from the lumbar spinal cord of pre-symptomatic G93A mouse ([@bib11]). Thus, SOD1^G93A^ may prime adult motor neurons for outgrowth and regeneration through a positive activation of genes that regulate the actin cytoskeleton. However, it should be noted that many of the initially resistant motor neurons eventually succumb to ALS ([@bib48]). The positive influence of mutant SOD1 expression on adult motor neuron regeneration most likely reflects an intermediate state occurring before cytotoxicity overwhelms the cells. However, instead of trying to completely silence mutant SOD1 expression, as with antisense oligonucleotide therapy ([@bib49]), capitalizing on mutant SOD1\'s pro-regenerative effects while combating its toxicity could be a useful strategy for future therapeutics.

Limitations of the Study {#sec3.1}
------------------------

The results of this study were not corroborated with *in vivo* studies of motor neuron regeneration, so the direct relevance of this work to ALS disease progression remains to be determined.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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